TickerFacts.

A business in context

VNDA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-053855

  2. 8-K · Current report

    Report date 2026-08-05 · 0001628280-26-053308 · Items 2.02,9.01

  3. 4 · Ownership change

    Report date 2026-06-04 · 0001193125-26-261871

  4. 4 · Ownership change

    Report date 2026-06-04 · 0001193125-26-261811

  5. 4 · Ownership change

    Report date 2026-06-04 · 0001193125-26-261806

  6. 4 · Ownership change

    Report date 2026-06-04 · 0001193125-26-261800

  7. 4 · Ownership change

    Report date 2026-06-04 · 0001193125-26-261790

  8. 4 · Ownership change

    Report date 2026-06-04 · 0001193125-26-261782

  9. 4 · Ownership change

    Report date 2026-06-04 · 0001193125-26-261768

  10. 8-K · Current report

    Report date 2026-06-04 · 0001628280-26-041298 · Items 5.07

  11. 4 · Ownership change

    Report date 2026-05-18 · 0001802653-26-000003

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-031667

  13. 8-K · Current report

    Report date 2026-05-06 · 0001628280-26-031241 · Items 2.02,9.01

  14. DEF 14A · Proxy statement

    Report date 2026-06-04 · 0001628280-26-026893

  15. 8-K · Current report

    Report date 2026-04-22 · 0001628280-26-026642 · Items 5.02,9.01

  16. 8-K · Current report

    Report date 2026-03-29 · 0001628280-26-023222 · Items 5.02

  17. 8-K · Current report

    Report date 2026-03-10 · 0001628280-26-016516 · Items 7.01

  18. 8-K · Current report

    Report date 2026-02-20 · 0001628280-26-010376 · Items 8.01,9.01

  19. 8-K · Current report

    Report date 2026-02-18 · 0001628280-26-009805 · Items 5.02,9.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-007460

  21. 8-K · Current report

    Report date 2026-02-11 · 0001628280-26-007256 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2026-01-07 · 0001628280-26-001273 · Items 8.01,9.01

  23. 8-K · Current report

    Report date 2025-12-30 · 0001628280-25-059155 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2025-12-04 · 0001628280-25-055393 · Items 8.01,9.01

  25. 8-K · Current report

    Report date 2025-11-28 · 0001628280-25-054225 · Items 8.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001628280-25-047317

  27. 8-K · Current report

    Report date 2025-10-29 · 0001628280-25-047112 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-10-01 · 0001628280-25-043489 · Items 8.01,9.01

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-036861

  30. 8-K · Current report

    Report date 2025-07-31 · 0001628280-25-036843 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-06-05 · 0001628280-25-029678 · Items 5.07

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-023448

  33. 8-K · Current report

    Report date 2025-05-07 · 0001628280-25-023154 · Items 2.02,9.01

  34. DEF 14A · Proxy statement

    Report date 2025-06-05 · 0001628280-25-019987

  35. 8-K · Current report

    Report date 2025-03-14 · 0001193125-25-055287 · Items 7.01

  36. 8-K · Current report

    Report date 2025-02-18 · 0001193125-25-030780 · Items 5.02

  37. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-005761

  38. 8-K · Current report

    Report date 2025-02-13 · 0001628280-25-005406 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2025-01-25 · 0001193125-25-012740 · Items 7.01

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001628280-24-045970

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 8 transaction rows8AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 1 transaction rows1G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

9 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-04
2026-06-08
McGuire Daniel PatrickA · Grant / award
Acquired
Common Stock80000.00.0
2026-06-04
2026-06-08
Chrousos PhaedraA · Grant / award
Acquired
Common Stock41600.00.0
2026-06-04
2026-06-08
Duncan Charles CliffA · Grant / award
Acquired
Common Stock41600.00.0
2026-06-04
2026-06-08
DUGAN RICHARD WA · Grant / award
Acquired
Common Stock41600.00.0
2026-06-04
2026-06-08
Ward Anne SempowskiA · Grant / award
Acquired
Common Stock41600.00.0
2026-06-04
2026-06-08
Honore TageA · Grant / award
Acquired
Common Stock41600.00.0
2026-06-04
2026-06-08
Mitchell Stephen RayA · Grant / award
Acquired
Common Stock41600.00.0
2026-05-18
2026-05-20
Mitchell Stephen RayG · Gift
Disposed
Common Stock25836.00.0
2026-04-22
2026-04-24
Duncan Charles CliffA · Grant / award
Acquired
Common Stock57101.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001347178Vanda Pharmaceuticals Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$198.77M$211.58M
    2023-12-31$192.64M$211.10M
    2022-12-31$254.38M$290.20M
    2021-12-31$268.68M$331.04M
    2020-12-31$248.17M$320.18M
    2019-12-31$227.19M$296.72M
    2018-12-31$193.12M$256.79M
    2017-12-31$165.08M$224.88M

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗